Inventor · Woodbury, MN, US

Mark A. Tomai

15Patents
12h-index
30Co-inventors
78Inventor score

Filing activity: Mar 24, 1994 → Oct 3, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US6039969A Immune response modifier compounds for treatment of TH2 mediated and related diseases Emerging Cross-Sectional Technologies 284 Expired
US6083505A 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants Human Necessities 230 Expired
US5939090A Gel formulations for topical drug delivery Human Necessities 228 Expired
US6558951B1 Maturation of dendritic cells with immune response modifying compounds Emerging Cross-Sectional Technologies 206 Expired
US6376669B1 Dye labeled imidazoquinoline compounds Physics 201 Expired
US6200592A Immine response modifier compounds for treatment of TH2 mediated and related diseases Emerging Cross-Sectional Technologies 142 Expired
US6696076B2 Immune response modifier compounds for treatment of TH2 mediated and related diseases Emerging Cross-Sectional Technologies 111 Expired
US6610319B2 Immune response modifier compounds for treatment of TH2 mediated and related diseases Emerging Cross-Sectional Technologies 104 Expired
US6365166B2 Gel formulations for topical drug delivery Human Necessities 85 Expired
US6916925B1 Dye labeled imidazoquinoline compounds Physics 66 Expired
US7226928B2 Methods for the treatment of periodontal disease Human Necessities 66 Expired
US6630588B2 Dye labeled imidazoquinoline compounds Physics 66 Expired
US9801947B2 Methods and compositions for enhancing immune response Emerging Cross-Sectional Technologies 7 Active
US12099046B2 Manufacturing a biologic pharmaceutical using causal models Human Necessities 0 Active
US8940755B2 Therapeutic combinations and methods including IRM compounds Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.